Cannabipiperidiethanone|  | 
|
| Legal status |  | 
|---|
|
| 
2-(2-Methoxyphenyl)-1-[1-([1-methylpiperidin-2-yl]methyl)indol-3-yl]ethanone
 | 
| CAS Number |  | 
|---|
| ChemSpider |  | 
|---|
| UNII |  | 
|---|
| CompTox Dashboard (EPA) |  | 
|---|
|
| Formula | C24H28N2O2 | 
|---|
| Molar mass | 376.500 g·mol−1 | 
|---|
| 3D model (JSmol) |  | 
|---|
| 
COc2ccccc2CC(=O)c(c4c1cccc4)cn1CC3CCCCN3C
 | 
| 
InChI=1S/C24H28N2O2/c1-25-14-8-7-10-19(25)16-26-17-21(20-11-4-5-12-22(20)26)23(27)15-18-9-3-6-13-24(18)28-2/h3-6,9,11-13,17,19H,7-8,10,14-16H2,1-2H3Key:AJSBNWAHEDVQJT-UHFFFAOYSA-N
 | 
Cannabipiperidiethanone (CPE or 1-(N-methylpiperidin-2-ylmethyl)-3-(2-methoxyphenylacetyl)indole) is a synthetic cannabinoid that has been found to be an ingredient of "herbal smoking blends" sold in Japan.
The drug's binding affinity was measured at the CB1 and CB2 receptors and it was found to have an IC50 of 591 nM at CB1 and 968 nM at CB2, making it 2.3 times and 9.4 times weaker than JWH-250 at these two targets respectively.[1]
In the United States, CB1 receptor agonists of the 3-phenylacetylindole class such as cannabipiperidiethanone are Schedule I Controlled Substances.[2]
See also
References
|  | 
|---|
| Phytocannabinoids (comparison)
 | | Cannabibutols |  | 
|---|
 | Cannabichromenes |  | 
|---|
 | Cannabicyclols |  | 
|---|
 | Cannabidiols |  | 
|---|
 | Cannabielsoins |  | 
|---|
 | Cannabigerols |  | 
|---|
 | Cannabiphorols |  | 
|---|
 | Cannabinols | 
CBN
CBNACBN-C1CBN-C2CBN-C4CBNM
CBND
CBNP
CBVD
 | 
|---|
 | Cannabitriols |  | 
|---|
 | Cannabivarins |  | 
|---|
 | Delta-3-tetrahydrocannabinols |  | 
|---|
 | Delta-4-tetrahydrocannabinols |  | 
|---|
 | Delta-7-tetrahydrocannabinols |  | 
|---|
 | Delta-8-tetrahydrocannabinols |  | 
|---|
 | Delta-9-tetrahydrocannabinols |  | 
|---|
 | Delta-10-Tetrahydrocannabinols |  | 
|---|
 | Delta-11-Tetrahydrocannabinols |  | 
|---|
 | Miscellaneous cannabinoids |  | 
|---|
 | Active metabolites |  | 
|---|
 | 
|---|
| Endocannabinoids |  | 
|---|
| Synthetic cannabinoid
 receptor
 agonists /
 neocannabinoids
 | | Classical cannabinoids (dibenzopyrans)
 |  | 
|---|
 | Non-classical cannabinoids
 |  | 
|---|
 | Adamantoylindoles |  | 
|---|
 | Benzimidazoles |  | 
|---|
 | Benzoylindoles |  | 
|---|
 | Cyclohexylphenols |  | 
|---|
 | Eicosanoids |  | 
|---|
 | Indazole-3- carboxamides
 |  | 
|---|
 | Indole-3-carboxamides |  | 
|---|
 | Indole-3-carboxylates |  | 
|---|
 | Naphthoylindazoles |  | 
|---|
 | Naphthoylindoles |  | 
|---|
 | Naphthoylpyrroles |  | 
|---|
 | Naphthylmethylindenes |  | 
|---|
 | Naphthylmethylindoles |  | 
|---|
 | Phenylacetylindoles |  | 
|---|
 | Pyrazolecarboxamides |  | 
|---|
 | Tetramethylcyclo- propanoylindazoles
 |  | 
|---|
 | Tetramethylcyclo- propanoylindoles
 |  | 
|---|
 | Others |  | 
|---|
 | 
|---|
| Allosteric CBRTooltip Cannabinoid receptor ligands |  | 
|---|
| Endocannabinoid enhancers
 (inactivation inhibitors)
 |  | 
|---|
| Anticannabinoids (antagonists/inverse
 agonists/antibodies)
 |  | 
|---|
|  | 
|  | 
|---|
| Receptor (ligands)
 | | CB1Tooltip Cannabinoid receptor type 1 | | Agonists (abridged,
 full list)
 |  | 
|---|
 | Inverse agonists |  | 
|---|
 | Antagonists |  | 
|---|
 | 
|---|
 | CB2Tooltip Cannabinoid receptor type 2 | | Agonists | 
2-AG2-AGE (noladin ether)3,3'-Diindolylmethane4-O-Methylhonokiolα-Amyrin · β-AmyrinA-796,260A-834,735A-836,339AM-1172AM-1221AM-1235AM-1241AM-2232AnandamideAZ-11713908CannabinolCaryophylleneCB-13CBS-0550CP 55,940GW-405,833 (L-768,242)GW-842,166XHU-308JTE 7-31JWH-007JWH-015JWH-018JWH-73JWH-133L-759,633L-759,656Lenabasum (anabasum)MagnololMDA-19NabitanNADAOlorinab (APD-371)PF-03550096S-444,823SER-601Serinolamide AUR-144TedalinabTHC (dronabinol)THCVTetrahydromagnololVirodhamine
 | 
|---|
 | Antagonists |  | 
|---|
 | 
|---|
 | NAGly (GPR18)
 |  | 
|---|
 | GPR55 |  | 
|---|
 | GPR119 |  | 
|---|
 | 
|---|
| Transporter (modulators)
 | | eCBTsTooltip Endocannabinoid transporter |  | 
|---|
 | 
|---|
| Enzyme (modulators)
 | | FAAHTooltip Fatty acid amide hydrolase |  | 
|---|
 | MAGL |  | 
|---|
 | ABHD6 | 
Inhibitors: JZP-169JZP-430KT182KT185KT195KT203LEI-106ML294ML295ML296UCM710WWL-70
 | 
|---|
 | ABHD12 |  | 
|---|
 | 
|---|
| Others | 
Others: 2-PG (directly potentiates activity of 2-AG at CB1 receptor)ARN-272 (FAAH-like anandamide transporter inhibitor)
 | 
|---|
| 
See also Receptor/signaling modulators Cannabinoids (cannabinoids by structure)
 |